Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Crispr Therapeutics Insider Sold Shares Worth $720,373, According to a Recent SEC Filing

Crispr Therapeutics Insider Sold Shares Worth $720,373, According to a Recent SEC Filing

MT newswireMT newswire2026/10/16 21:55
05:55 PM EDT, 10/16/2026 (MT Newswires) -- Simeon George, Director, on October 14, 2026, sold 14,514 shares in Crispr Therapeutics (CRSP) for $720,373. Following the Form 4 filing with the SEC, George has control over a total of 2,054,249 common shares of the company, with 15,486 shares held directly and 2,038,763 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1674416/000119312526424317/xslF345X05/ownership.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!